Plasmid-Mediated Production of Staphylococcin in Bacteriophage Type 71 Staphylococcus aureus
Author(s) -
Adnan S. Dajani,
Zaiga Taube
Publication year - 1974
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.5.6.594
Subject(s) - ethidium bromide , bacteriocin , acridine orange , staphylococcus aureus , microbiology and biotechnology , plasmid , bacteriophage , chemistry , acriflavine , sodium dodecyl sulfate , biology , bacteria , escherichia coli , biochemistry , dna , antimicrobial , gene , apoptosis , genetics
Staphylococcin production by Staphylococcus aureus strain C55 was eliminated when producing strains were exposed to various curing treatments. Acridine orange, ethidium bromide, and sodium dodecyl sulfate each effected less than 15% cure rates in treated cells. Rifampin eliminated the staphylococcin in 83% of treated isolates, and growth at 42 C resulted in a 97% cure rate. Curing of staphylococcin production and elimination of penicillinase plasmid were independent of one another. Several characteristics of the cured strains were examined and compared with the bacteriocin-producing strains. Whereas bacteriocin-producing cells were resistant to the bactericidal action of the staphylococcin and failed to adsorb it, cured cells adsorbed the staphylococcin and were susceptible to its lethal effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom